SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,702,000 | +8.0% | 2,308,079 | +94.6% | 1.54% | +12.8% |
| Q4 2018 | $13,613,000 | +134.0% | 1,185,831 | +245.5% | 1.36% | +159.9% |
| Q3 2018 | $5,818,000 | -72.9% | 343,231 | -77.3% | 0.52% | -74.3% |
| Q2 2018 | $21,437,000 | +542.6% | 1,509,671 | +578.8% | 2.04% | +358.7% |
| Q3 2017 | $3,336,000 | -85.2% | 222,388 | -91.3% | 0.44% | -88.9% |
| Q2 2017 | $22,599,000 | – | 2,568,119 | – | 4.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |